Tratamento da hidradenite supurativa com adalimumabe – experiência da prática diária em centro terciário de Lisboa, Portugal
Open Access
- 1 November 2022
- journal article
- Published by Elsevier in Anais Brasileiros de Dermatologia (Versão em Português)
- Vol. 97 (6) , 816-819
Abstract
No abstract availableThis publication has 9 references indexed in Scilit:
- Evaluating patients' unmet needs in hidradenitis suppurativa: Results from the Global Survey Of Impact and Healthcare Needs (VOICE) ProjectJournal of the American Academy of Dermatology, 2020
- Adalimumab medium-term dosing strategy in moderate-to-severe hidradenitis suppurativa: integrated results from the phase III randomized placebo-controlled PIONEER trialsBritish Journal of Dermatology, 2019
- Long-term adalimumab efficacy in patients with moderate-to-severe hidradenitis suppurativa/acne inversa: 3-year results of a phase 3 open-label extension studyJournal of the American Academy of Dermatology, 2019
- Long-term adalimumab treatment of hidradenitis suppurativa: Results and practical insights from a real-life experienceDermatologic Therapy, 2018
- Hidradenitis suppurativa/acne inversa: a practical framework for treatment optimization – systematic review and recommendations from the HS ALLIANCE working groupJournal of the European Academy of Dermatology and Venereology, 2018
- Hidradenitis SuppurativaJAMA, 2017
- Targeted treatments for hidradenitis suppurativa: a review of the current literature and ongoing clinical trialsJournal of Dermatological Treatment, 2017
- Manejo del paciente con hidradenitis supurativaActas Dermo-Sifiliograficas, 2016
- Two Phase 3 Trials of Adalimumab for Hidradenitis SuppurativaNew England Journal of Medicine, 2016